Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Subcutaneous (SC) Cinryze® (C1 inhibitor (C1 INH) with Recombinant Human Hyaluronidase (rHuPH20) in Subjects with Hereditary Angioedema (HAE)

✍ Scribed by Schranz, J.; Levy, R.; Lumry, W.; Manning, M.; Jacobs, J.; Dychter, S.S.; LaBarre, M.J.; Phillips, A.; Gelone, S.; Broom, C.

• Book ID: 119286627
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 38 KB
• Volume: 129
• Category: Article
• ISSN: 1097-6825
• DOI: 10.1016/j.jaci.2012.01.022